PUVA Therapy In The Treatment of Localized Scleroderma PDF Print E-mail
Monday, 16 November 2009 11:25
In localized Scleroderma, disease activity would tend to stop spontaneously over time. Treatment is important to reduce disabilities caused by the active phases of disease. According to Medifocus.com, there are three treatments used in the treatment of localized Scleroderma. These would include:
  • PUVA Therapy
  • Topical Photodynamic Therapy
  • Drug Therapy.

Today, we look at the PUVA Therapy.

PUVA Therapy or psoralen photochemotherapy refers to treatment with a combination of drugs known as Psoralens and UVA light (long wave ultraviolet radiation). Psoralens are compounds found in many plants which make the skin temporarily sensitive to UVA. The ancient Egyptians were the first to use psoralens for the treatment of skin diseases thousands of years ago. Medicine psoralens include methoxsalen (8-methoxypsoralen), 5-methoxypsoralen and trisoralen.

taken from http://www.flickr.com/photos/aenertia/2913943471/in/photostream/ via creative commonsPUVA therapy is used to treat several severe skin conditions including vitiligo, psoriasis, and dermatitis. It is also used in the treatment of localized Scleroderma because studies have been shown a significant reduction of collagen production with this treatment. However, some reports have indicated that the improvement in the systemic patients were less clear, and required further study and trials. According to one NY Times feature, PUVA therapy may prove useful for patients with early-onset diffuse Scleroderma, as this treatment is known to increase the risk for skin cancer.

PUVA therapy can be performed in a doctor’s office on an outpatient basis. The initial step in this treatment involves the administration of psoralen to the patient, which may be done either orally or topically. This is then followed by timed exposure to the ultraviolet light from the lamp. For oral PUVA, methoxsalen capsules are taken two hours before the appointment for treatment. For bathwater PUVA, the patient soaks in a bath containing a solution of psoralens. In most cases, treatment is undertaken two or three times each week.

As indicated above, PUVA is not without its risks and side effects.
  • There may be burning, where an overdose of PUVA results in a sunburn-like reaction called phototoxic erythema.
  • Temporary mild pricking or itching of the skin is common after treatment.
  • Nausea occurs in a quarter of those treated with psoralens.
  • PUVA usually leads to tanning which lasts several months. Although the skin appears brown it may still burn easily on sun exposure.
  • If the eyes are not protected from UV radiation, keratitis may occur. This results in red sore gritty eyes and can be very unpleasant.
  • Extensive PUVA treatment results in premature aging changes and can increase the chance of skin cancer.
The reading on PUVA therapy is quite extensive, and we have assembled a number of links, which would allow you to get started on the topic.
 
More articles :

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» Prevalence and Correlates of Sleep Disturbance in Systemic Sclerosis

Tracy Frech, Ron D. Hays, Paul Maranian, Philip J. Clements, Daniel E. Furst and Dinesh KhannaObjective:Rheumatologic disorders are associated with sleep disturbances. This study examines sleep disturbance correlates in patients with...

» 6 Secrets of Getting Better Doctor Care

To be a smart patient, you can't be passive; you need to be a first-rate Sherlock Holmes. Like Holmes, smart patients ask intelligent questions and have the instincts (and guts) to politely challenge things they don't understand. They don't need to...

» Targeted Therapy for Systemic Sclerosis: How Close are We?

Manuel Ramos-Casals; Vicent Fonollosa-Pla; Pilar Brito-Zerón; Antoni Sisó-AlmirallPosted: 09/14/2010; Nat Rev Rheumatol. 2010;6(5):269-278. © 2010 Nature Publishing GroupDespite recent etiopathogenetic advances, systemic sclerosis continues to be...

» Rare Diseases Day

Febuary 28th, 2010 was Rare Diseases Day, and it was marked with a variety of events and activities all over the world - as well as with plenty of citizen media and online participation. The goal was to raise awareness about so-called. These are...

» Courts Makes A Contribution To The Scleroderma Care Foundation

(Unicomer Trinidad Limited) graciously contributed on Firday, three Juicers to the . In a statement by Foundation Vice-President, , "Juicing fresh fruits and vegetables is the best way to obtain maximum nutrition. When someone finds themselves...